{"id":"W2154753744","doi":"10.1093/annonc/mdu205","title":"A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; University of Toronto; University of Alberta","funders":"","keywords":"Tremelimumab; Medicine; Tolerability; Gemcitabine; Internal medicine; Oncology; Pancreatic cancer; Chemotherapy; Gastroenterology; Cancer; Adverse effect; Immunotherapy; Ipilimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005020084,0.0001444152,0.0006677557,0.0002958443,0.00001306475,0.000002653924,0.00006036698,0.00007807962,0.00008128395],"category_scores_gemma":[0.00006471608,0.0001035742,0.00005634564,0.0004436697,0.0001460508,0.00009194277,0.000006639694,0.0001048947,5.248646e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000111173,"about_ca_system_score_gemma":0.0002838178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001159313,"about_ca_topic_score_gemma":0.001297962,"domain_scores_codex":[0.9986355,0.0001785659,0.0005460071,0.0001965007,0.0002495798,0.0001938189],"domain_scores_gemma":[0.9989377,0.0001690761,0.0004367028,0.0001740092,0.0002415468,0.00004091925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5894599,0.01204339,0.0568247,0.000206112,0.00038786,0.000007318441,0.00154098,0.00004543885,0.00370829,0.00008787647,0.0001172141,0.3355709],"study_design_scores_gemma":[0.5614669,0.06506621,0.366352,0.0004525748,0.0001404723,0.000002658847,0.0001353566,0.0005375356,0.004583063,0.0001422006,0.0009642335,0.0001568149],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965023,0.0001535821,0.00008314147,0.001528051,0.00005644939,0.001209597,0.00001250305,0.000007361607,0.0004470349],"genre_scores_gemma":[0.9987406,0.00023829,0.000288371,0.0004937302,0.0000236793,0.0001084292,0.00005738437,0.0000177161,0.00003184918],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3354141,"threshold_uncertainty_score":0.4223635,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04119301553983473,"score_gpt":0.3675221896947738,"score_spread":0.3263291741549391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}